John Horton
Duke University · 112 works · 20,989 citations · h-index 35
Top works
- Toxicity and response criteria of the Eastern Cooperative Oncology Group
- Prognostic effect of weight loss prior tochemotherapy in cancer patients
- Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials
- Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study
- THE MANAGEMENT OF METASTASES TO THE BRAIN BY IRRADIATION AND CORTICOSTEROIDS
- Estimated Effect of Breast Self-Examination and Routine Physician Examinations on Breast-Cancer Mortality
- Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials
- Intracavitary bleomycin in the management of malignant effusions
- Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.
- Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients
- Vincristine treatment of advanced cancer: a cooperative study of 392 cases.
- A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma
- 5-Fluorouracil in Cancer: An Improved Regimen
- Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma
- Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer
- Fatigue in Women Receiving Adjuvant Chemotherapy for Breast Cancer
- Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials
- Clinical features of tumor metastasis to the pituitary
- Hormonal treatment for metastatic breast cancer. An eastern cooperative oncology group phase III trial comparing aminoglutethimide to tamoxifen
- A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer